Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology

Detailed price information for Marker Therapeutics Inc (MRKR-Q) from The Globe and Mail including charting and trades.

Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer

Detailed price information for Marker Therapeutics Inc (MRKR-Q) from The Globe and Mail including charting and trades.
The Morning Journal

Meeting set to discuss another health study related to derailment in East Palestine

Health experts are unveiling yet another step in studying the long-term effects of the February 2023 train derailment within East Palestine. The East Palestine Train Derailment Health Research Program ...